Shyam Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.93 M
- Company Age 30 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 6.64 M
- Revenue Growth 7.08%
- Profit Growth 45.60%
- Ebitda -3.24%
- Net Worth 4.88%
- Total Assets -1.84%
About Shyam Pharma
Shyam Pharma Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 January 1995 and has a history of 30 years and one month. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.93 M.
The company has closed loans amounting to ₹6.64 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Satyanarayana Gottumukkala and Ramana Chekuri serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24231TG1995PTC019174
-
Company No.
019174
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Jan 1995
-
Date of AGM
31 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Shyam Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satyanarayana Gottumukkala
|
Managing Director | 11-Jan-1995 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Ramana Chekuri
|
Director | 24-Nov-2022 | Current |
Financial Performance of Shyam Pharma.
Shyam Pharma Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 7.08% increase. The company also saw a substantial improvement in profitability, with a 45.6% increase in profit. The company's net worth moved up by a moderate rise of 4.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shyam Pharma?
In 2017, Shyam Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Gouthama Properties Private LimitedRamana Chekuri is a mutual person
Charges (Loans)
₹0
₹6.64 M
Charges Breakdown by Lending Institutions
- Corporation Bank : 0.53 Cr
- Oriental Bank Of Commerce : 0.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Dec 2014 | Corporation Bank | ₹0.33 M | Satisfied |
| 14 Aug 2009 | Corporation Bank | ₹1.50 M | Satisfied |
| 19 Jan 2005 | Corporation Bank | ₹3.50 M | Satisfied |
| 07 May 2002 | Oriental Bank Of Commerce | ₹0.62 M | Satisfied |
| 27 Mar 1998 | Oriental Bank Of Commerce | ₹0.69 M | Satisfied |
How Many Employees Work at Shyam Pharma?
Unlock and access historical data on people associated with Shyam Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shyam Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shyam Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
